In four international centers, PhD. candidate Marinka Hol investigated facial abnormalities and other late effects of tumors in children. Marinka will defend her thesis on April 12 ➡️ bit.ly/3TS7UN2
Antoni van Leeuwenhoek UvA Amsterdam PrinsesMáximaCentrum

Researchers Thijn Brummelkamp, Bernards Laboratory@NKI, and The Agami Lab from the NKI and Oncode Institute will each be awarded a prestigious European Research Council (ERC) Advanced Grant today. This will allow them to deepen their innovative and often surprising research ideas ➡️ bit.ly/4aMY4mi

Gaining experience in New York for a year unexpectedly formed the basis of Floris Verheij PhD research, and brings good news for patients with rectal cancer. Floris will defend his thesis on April 12 ➡️ bit.ly/4cSVE7C Antoni van Leeuwenhoek Maastricht University Amsterdam UMC

Out now: CD8-targeted IL2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool by Paulien Kaptein @Thommen_ds in Cancer Discovery #publicationoftheweek ⬇️ bit.ly/3JdKjkM

NKI researchers have compiled a detailed catalog of bacteria living in cancer metastases. They shed light on their diversity and how they might interact with cancer cells and their surroundings ➡️ bit.ly/3VR9GjN

@KWF_nl Oncode Institute Cell Press

📅The ESLAV-ECLAM Summer School will be organized from June 19 to 21 at the Netherlands Cancer Institute in close collaboration with @herseninstituut. The 2024 ESLAV-ECAM Summer School is focused on animal facility management. More information or sign up➡️ bit.ly/3xBIdsh

“Cabazitaxel is a drug prescribed to patients with end stage prostate cancer, which is delivered intravenously. It would be beneficial for this group if they could take their medicine at home in tablet form to avoid travelling to the hospital.' ➡️ bit.ly/4apa0ej #PhD

Out now: Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors by Alberto Gil-Jimenez Alberto Gil Jimenez in Nature Communications #publicationoftheweek ⬇️ bit.ly/4aJ0eDh

Right in time to celebrate the lab’s 4 yr anniversary, we are excited to share our new work in Cancer Discovery, in which we explore a CD8-targeted IL2 to revive dysfunctional T cells in anti-PD1 resistant human cancers 1/n aacrjournals.org/cancerdiscover…

'In theory, cancer treatment could be greatly improved by combining radiotherapy with immunotherapy. In reality, however, we see that this combination does not work well for all patients. Elselien defends her thesis on April 4 ➡️ bit.ly/3vtPk5J

Thanks to the efforts of PhD candidate Ruby van Stein Antoni van Leeuwenhoek UvA Amsterdam, the HIPEC treatment and comprehensive information about it are now available to all ovarian cancer patients. ➡️ bit.ly/3VP9PnQ

How to treat cancer that is resistant to immune checkpoint blockade therapy? That is what @Thommen_ds focus on in a new study on immunotherapy. ➡️ bit.ly/4cHSzqC

The Rising Tide Foundation For Clinical Research (RTFCCR) is awarding €800,000 to Jelle Wesseling's LORD study. This study investigates whether non-treatment of a common precursor abnormality of breast cancer is safe. Read more ➡️ bit.ly/4aRXZxV

At his farewell symposium, Rene Medema Rene Medema was appointed Knight in the Order of Lion of the Netherlands. He receives this royal honor for his significant contributions to cancer research and cancer care ➡️ bit.ly/3TU7sPl

Congratulations Rik!

So so happy to share our latest lab paper in Nature Communications dissecting the influence of oncogenic pathways on immune cell shaping in #HCC ! A 🧵 doi.org/10.1038/s41467… 1/n

To treat cancer, you have to inhibit cancer cells. Right? NKI Researchers did just the opposite. They achieved surprising results by overstimulating cancer cells in the lab and then hitting them at their weak spot: stress ➡️ bit.ly/3IQZvUW

#research #nki #cancerresearch

SocioEconomic Impact of cancer is underestimated and needs a strong policy and research agenda! Very proud on our Lancet Oncology paper from the Organisation of European Cancer Institutes Task Force with strong input from DKFZ and The Netherlands Cancer Institute groups! sciencedirect.com/science/articl…

NKI researcher Tineke Lenstra and her colleagues made an algorithm which allowed them to create incredibly detailed recordings of what happens inside a cell: something similar to a relay race occurs on our DNA ➡️ bit.ly/3ISXRCc

Out now: Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness by the group of Daniel Peeper and colleagues in Cancer Cell #publicationoftheweek ➡️ bit.ly/3TGoL6u